Patient engagement: Breaking through in digital

  Face-to-face engagement restrictions during the pandemic made remote engagement the only game in town for pharma and healthcare providers.  The speed at which both have risen to the challenge and adopted digital tools to solve urgent patient care and support needs has been striking. Most pharma players will have relaxed pre-pandemic standard operating procedures to get drugs and treatment advice to patients by any means.  And in a new Reuters Events Pharma survey, almost two thirds (63.2%) of respondents say their patient support programmes are able to meet current remote access conditions.  Now that the initial pressure on the healthcare ecosystem has eased, it is a good opportunity to consider unleashing the full potential of digital engagement. The pandemic has underscored the profound value of well thought through and well delivered digital engagement, says Peter Said, Head of Patient Engagement APAC at Bayer Australia.   “We have a big role to play not just around drugs and adherence but also supporting them through times of low mood, that may be impacted by social isolation, offering someone to talk to, helping work out how to get medications and so on,” he says. “People are becoming more connected via digital, which allows the exchange of information in a rapid fashion. We are able to engage with patients more with more agility, especially those connected patients in younger demographics.” Overcoming the tyranny of distance Remote and digital eng...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news